- Home
- TNGX vs NUS Comparison
TNGX vs NUS Comparison
Compare TNGX & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- NUS
- Stock Information
- Founded
- TNGX 2014
- NUS 1984
- Country
- TNGX United States
- NUS United States
- Employees
- TNGX N/A
- NUS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- NUS Other Pharmaceuticals
- Sector
- TNGX Health Care
- NUS Health Care
- Exchange
- TNGX Nasdaq
- NUS Nasdaq
- Market Cap
- TNGX 317.4M
- NUS 321.6M
- IPO Year
- TNGX N/A
- NUS 1996
- Fundamental
- Price
- TNGX $1.76
- NUS $8.16
- Analyst Decision
- TNGX Strong Buy
- NUS Hold
- Analyst Count
- TNGX 7
- NUS 2
- Target Price
- TNGX $12.33
- NUS $6.88
- AVG Volume (30 Days)
- TNGX 801.9K
- NUS 671.4K
- Earning Date
- TNGX 05-07-2025
- NUS 05-07-2025
- Dividend Yield
- TNGX N/A
- NUS 2.94%
- EPS Growth
- TNGX N/A
- NUS N/A
- EPS
- TNGX N/A
- NUS N/A
- Revenue
- TNGX $42,069,000.00
- NUS $1,732,084,000.00
- Revenue This Year
- TNGX N/A
- NUS N/A
- Revenue Next Year
- TNGX N/A
- NUS N/A
- P/E Ratio
- TNGX N/A
- NUS N/A
- Revenue Growth
- TNGX 15.17
- NUS N/A
- 52 Week Low
- TNGX $1.71
- NUS $5.95
- 52 Week High
- TNGX $12.02
- NUS $14.04
- Technical
- Relative Strength Index (RSI)
- TNGX 31.59
- NUS 58.36
- Support Level
- TNGX $1.80
- NUS $7.81
- Resistance Level
- TNGX $2.04
- NUS $8.35
- Average True Range (ATR)
- TNGX 0.21
- NUS 0.34
- MACD
- TNGX 0.01
- NUS -0.01
- Stochastic Oscillator
- TNGX 3.94
- NUS 77.72
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.